K Sorsdahl1, C van der Westhuizen2, M Neuman3, H A Weiss3, B Myers4,5. 1. Alan J. Flisher Centre for Public Mental Health, Department of Psychiatry & Mental Health, University of Cape Town, Cape Town, South Africa. Katherine.sorsdahl@uct.ac.za. 2. Alan J. Flisher Centre for Public Mental Health, Department of Psychiatry & Mental Health, University of Cape Town, Cape Town, South Africa. 3. MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, England. 4. Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa. 5. Department of Psychiatry & Mental Health, University of Cape Town, Cape Town, South Africa.
Abstract
BACKGROUND: Like many low- and middle-income countries, almost half of the proportion of the South African population is under the age of 25. Given the peak age of onset for most mental health problems is in adolescence, it is vital that adolescents have access to mental health counselling. There are several initiatives to increase access to mental health counselling in South Africa, primarily through the integration of counselling for common mental disorders (CMD) into primary health care services, but adolescents (15-18 years of age) generally do not utilize these services. To address this gap, we will undertake a study to explore the feasibility of conducting a trial of the effectiveness of a community-based mental health counselling intervention for adolescents at-risk for a CMD. METHODS: The study is a feasibility trial of the ASPIRE intervention, a four-session blended multi-component counselling intervention adapted for South African adolescents at risk for depression and alcohol use disorders. We will enrol 100 adolescents from community settings and randomly assign them to the ASPIRE intervention or a comparison condition. Feasibility measures, such as rates of recruitment, consent to participate in the trial and retention, will be calculated. Qualitative interviews with participants and counsellors will explore the acceptability of the intervention. The primary outcomes for a subsequent trial would be reductions in symptoms of depression and days of heavy drinking which will be measured at baseline, 6 weeks, and 3 months post-randomization. DISCUSSION: This feasibility trial using a mixed-methods design will allow us to determine whether we can move forward to a larger effectiveness trial of the ASPIRE intervention. TRIAL REGISTRATION: The trial is registered with the Pan African Clinical Trials Registry (PACTR20200352214510). Registered 28 February 2020-retrospectively registered, https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9795.
BACKGROUND: Like many low- and middle-income countries, almost half of the proportion of the South African population is under the age of 25. Given the peak age of onset for most mental health problems is in adolescence, it is vital that adolescents have access to mental health counselling. There are several initiatives to increase access to mental health counselling in South Africa, primarily through the integration of counselling for common mental disorders (CMD) into primary health care services, but adolescents (15-18 years of age) generally do not utilize these services. To address this gap, we will undertake a study to explore the feasibility of conducting a trial of the effectiveness of a community-based mental health counselling intervention for adolescents at-risk for a CMD. METHODS: The study is a feasibility trial of the ASPIRE intervention, a four-session blended multi-component counselling intervention adapted for South African adolescents at risk for depression and alcohol use disorders. We will enrol 100 adolescents from community settings and randomly assign them to the ASPIRE intervention or a comparison condition. Feasibility measures, such as rates of recruitment, consent to participate in the trial and retention, will be calculated. Qualitative interviews with participants and counsellors will explore the acceptability of the intervention. The primary outcomes for a subsequent trial would be reductions in symptoms of depression and days of heavy drinking which will be measured at baseline, 6 weeks, and 3 months post-randomization. DISCUSSION: This feasibility trial using a mixed-methods design will allow us to determine whether we can move forward to a larger effectiveness trial of the ASPIRE intervention. TRIAL REGISTRATION: The trial is registered with the Pan African Clinical Trials Registry (PACTR20200352214510). Registered 28 February 2020-retrospectively registered, https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9795.
Authors: Ronald C Kessler; Matthias Angermeyer; James C Anthony; Ron DE Graaf; Koen Demyttenaere; Isabelle Gasquet; Giovanni DE Girolamo; Semyon Gluzman; Oye Gureje; Josep Maria Haro; Norito Kawakami; Aimee Karam; Daphna Levinson; Maria Elena Medina Mora; Mark A Oakley Browne; José Posada-Villa; Dan J Stein; Cheuk Him Adley Tsang; Sergio Aguilar-Gaxiola; Jordi Alonso; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Patricia Berglund; Michael J Gruber; Maria Petukhova; Somnath Chatterji; T Bedirhan Ustün Journal: World Psychiatry Date: 2007-10 Impact factor: 49.548
Authors: Kati Tiirikainen; Henna Haravuori; Klaus Ranta; Riittakerttu Kaltiala-Heino; Mauri Marttunen Journal: Psychiatry Res Date: 2018-12-03 Impact factor: 3.222
Authors: Sarah A Mossman; Marissa J Luft; Heidi K Schroeder; Sara T Varney; David E Fleck; Drew H Barzman; Richard Gilman; Melissa P DelBello; Jeffrey R Strawn Journal: Ann Clin Psychiatry Date: 2017-11 Impact factor: 1.567
Authors: Ronald C Kessler; G Paul Amminger; Sergio Aguilar-Gaxiola; Jordi Alonso; Sing Lee; T Bedirhan Ustün Journal: Curr Opin Psychiatry Date: 2007-07 Impact factor: 4.741
Authors: George C Patton; Susan M Sawyer; John S Santelli; David A Ross; Rima Afifi; Nicholas B Allen; Monika Arora; Peter Azzopardi; Wendy Baldwin; Christopher Bonell; Ritsuko Kakuma; Elissa Kennedy; Jaqueline Mahon; Terry McGovern; Ali H Mokdad; Vikram Patel; Suzanne Petroni; Nicola Reavley; Kikelomo Taiwo; Jane Waldfogel; Dakshitha Wickremarathne; Carmen Barroso; Zulfiqar Bhutta; Adesegun O Fatusi; Amitabh Mattoo; Judith Diers; Jing Fang; Jane Ferguson; Frederick Ssewamala; Russell M Viner Journal: Lancet Date: 2016-05-09 Impact factor: 79.321
Authors: M Dawn Teare; Munyaradzi Dimairo; Neil Shephard; Alex Hayman; Amy Whitehead; Stephen J Walters Journal: Trials Date: 2014-07-03 Impact factor: 2.279
Authors: Jessica Deighton; Tim Croudace; Peter Fonagy; Jeb Brown; Praveetha Patalay; Miranda Wolpert Journal: Child Adolesc Psychiatry Ment Health Date: 2014-04-29 Impact factor: 3.033